180 related articles for article (PubMed ID: 11243860)
21. Comparison of anti-hyperglycemic effect amongst vanadium, molybdenum and other metal maltol complexes.
Thompson KH; Chiles J; Yuen VG; Tse J; McNeill JH; Orvig C
J Inorg Biochem; 2004 May; 98(5):683-90. PubMed ID: 15134913
[TBL] [Abstract][Full Text] [Related]
22. Possible mode of action for insulinomimetic activity of vanadyl(IV) compounds in adipocytes.
Kawabe K; Yoshikawa Y; Adachi Y; Sakurai H
Life Sci; 2006 May; 78(24):2860-6. PubMed ID: 16337244
[TBL] [Abstract][Full Text] [Related]
23. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
[TBL] [Abstract][Full Text] [Related]
24. Hypoglycemic effect of hot-water extract of adzuki (Vigna angularis) in spontaneously diabetic KK-A(y) mice.
Itoh T; Kobayashi M; Horio F; Furuichi Y
Nutrition; 2009 Feb; 25(2):134-41. PubMed ID: 18929464
[TBL] [Abstract][Full Text] [Related]
25. Insulinomimetic Zn(II) complexes as evaluated by both glucose-uptake activity and inhibition of free fatty acids release in isolated rat adipocytes.
Nishide M; Yoshikawa Y; Yoshikawa EU; Matsumoto K; Sakurai H; Kajiwara NM
Chem Pharm Bull (Tokyo); 2008 Aug; 56(8):1181-3. PubMed ID: 18670123
[TBL] [Abstract][Full Text] [Related]
26. Anti-hyperglycemic Effect of Long-Term Bis(hinokitiolato)zinc Complex ([Zn(hkt)
Naito Y; Yoshikawa Y; Shintani M; Kamoshida S; Kajiwara N; Yasui H
Biol Pharm Bull; 2017; 40(3):318-326. PubMed ID: 28250273
[TBL] [Abstract][Full Text] [Related]
27. Antidiabetic actions of arachidonic acid and zinc in genetically diabetic Goto-Kakizaki rats.
Song MK; Hwang IK; Rosenthal MJ; Harris DM; Yamaguchi DT; Yip I; Go VL
Metabolism; 2003 Jan; 52(1):7-12. PubMed ID: 12524655
[TBL] [Abstract][Full Text] [Related]
28. Effects of bis(alpha-furancarboxylato)oxovanadium(IV) on glucose metabolism in fat-fed/streptozotocin-diabetic rats.
Niu Y; Liu W; Tian C; Xie M; Gao L; Chen Z; Chen X; Li L
Eur J Pharmacol; 2007 Oct; 572(2-3):213-9. PubMed ID: 17651728
[TBL] [Abstract][Full Text] [Related]
29. Oral administration of a zinc complex improves type 2 diabetes and metabolic syndromes.
Adachi Y; Yoshida J; Kodera Y; Kiss T; Jakusch T; Enyedy EA; Yoshikawa Y; Sakurai H
Biochem Biophys Res Commun; 2006 Dec; 351(1):165-70. PubMed ID: 17052688
[TBL] [Abstract][Full Text] [Related]
30. Antidiabetic activities of Tecoma stans (L.) Juss. ex Kunth.
Aguilar-Santamaría L; Ramírez G; Nicasio P; Alegría-Reyes C; Herrera-Arellano A
J Ethnopharmacol; 2009 Jul; 124(2):284-8. PubMed ID: 19397980
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic properties of VO(dmpp)2 as assessed by in vitro and in vivo studies in type 2 diabetic GK rats.
Domingues N; Pelletier J; Ostenson CG; Castro MM
J Inorg Biochem; 2014 Feb; 131():115-22. PubMed ID: 24333827
[TBL] [Abstract][Full Text] [Related]
32. A Zinc(II)/poly(gamma-glutamic acid) complex as an oral therapeutic for the treatment of type-2 diabetic KKAy mice.
Karmaker S; Saha TK; Yoshikawa Y; Sakurai H
Macromol Biosci; 2009 Mar; 9(3):279-86. PubMed ID: 18989849
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological and pharmacokinetic studies of anti-diabetic tropolonato-Zn(II) complexes with Zn(S(2)O(2)) coordination mode.
Murakami H; Yasui H; Yoshikawa Y
Chem Pharm Bull (Tokyo); 2012; 60(9):1096-104. PubMed ID: 22976316
[TBL] [Abstract][Full Text] [Related]
34. Vanadium treatment of type 2 diabetes: a view to the future.
Thompson KH; Lichter J; LeBel C; Scaife MC; McNeill JH; Orvig C
J Inorg Biochem; 2009 Apr; 103(4):554-8. PubMed ID: 19162329
[TBL] [Abstract][Full Text] [Related]
35. GLP-1 effect upon the GPI/IPG system in adipocytes and hepatocytes from diabetic rats.
Márquez L; González N; Puente J; Valverde L; Villanueva-Peñacarrillo ML
Diabetes Nutr Metab; 2001 Oct; 14(5):239-44. PubMed ID: 11806463
[TBL] [Abstract][Full Text] [Related]
36. Potential insulinominetic agents of zinc(II) complexes with picolinamide derivatives: preparations of complexes, in vitro and in vivo studies.
Ueda E; Yoshikawa Y; Ishino Y; Sakurai H; Kojima Y
Chem Pharm Bull (Tokyo); 2002 Mar; 50(3):337-40. PubMed ID: 11911195
[TBL] [Abstract][Full Text] [Related]
37. The biomimetic [Cr(3)O(O(2)CCH(2)CH(3))(6)(H(2)O)(3)](+ )decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats.
Sun Y; Clodfelder BJ; Shute AA; Irvin T; Vincent JB
J Biol Inorg Chem; 2002 Sep; 7(7-8):852-62. PubMed ID: 12203022
[TBL] [Abstract][Full Text] [Related]
38. Effects of guggulsterone isolated from Commiphora mukul in high fat diet induced diabetic rats.
Sharma B; Salunke R; Srivastava S; Majumder C; Roy P
Food Chem Toxicol; 2009 Oct; 47(10):2631-9. PubMed ID: 19635521
[TBL] [Abstract][Full Text] [Related]
39. [Insulino-mimetic effects of bis (alpha-furancarboxylato) oxovanadium (IV) in vitro].
Li YR; Gao LH; Ma YL; Niu YF; Liu WP; Li L
Yao Xue Xue Bao; 2008 Mar; 43(3):318-22. PubMed ID: 18630272
[TBL] [Abstract][Full Text] [Related]
40. Antidiabetic effect of seishin-kanro-to in KK-Ay mice.
Miura T; Kako M; Ishihara E; Usami M; Yano H; Tanigawa K; Sudo K; Seino Y
Planta Med; 1997 Aug; 63(4):320-2. PubMed ID: 9270376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
